Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2021-0311
Abstract: Aim: To compare rates of biologic initiation after commencing treatment with apremilast (APR) versus methotrexate (MTX) in systemic-naive patients with psoriasis (PsO). Methods: This was a retrospective cohort study of systemic-naive patients with PsO who… read more here.
Keywords: versus methotrexate; apremilast; biologic initiation; systemic naive ... See more keywords